Dicerna Pharmaceuticals Profit Margin 2012-2021 | DRNA
Current and historical gross margin, operating margin and net profit margin for Dicerna Pharmaceuticals (DRNA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Dicerna Pharmaceuticals net profit margin as of June 30, 2021 is -72.28%.
|Dicerna Pharmaceuticals Annual Profit Margins
|Dicerna Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.